Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 03, 2022

SELL
$40.23 - $47.74 $38,902 - $46,164
-967 Reduced 9.51%
9,205 $401,000
Q4 2021

Feb 07, 2022

BUY
$38.88 - $45.31 $23,405 - $27,276
602 Added 6.29%
10,172 $449,000
Q2 2020

Jul 16, 2020

SELL
$37.87 - $43.58 $35,408 - $40,747
-935 Reduced 8.9%
9,570 $390,000
Q4 2018

Jan 07, 2019

SELL
$37.8 - $42.69 $37,800 - $42,690
-1,000 Reduced 8.69%
10,505 $401,000
Q3 2018

Oct 11, 2018

BUY
$39.75 - $42.69 $39,750 - $42,690
1,000 Added 9.52%
11,505 $462,000
Q4 2017

Jan 11, 2018

SELL
$35.34 - $41.9 $5,301 - $6,285
-150 Reduced 1.41%
10,505 $373,000
Q3 2017

Oct 06, 2017

BUY
$39.44 - $41.55 $420,233 - $442,715
10,655
10,655 $433,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.